SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-23-001509
Filing Date
2023-02-09
Accepted
2023-02-09 09:20:27
Documents
15
Period of Report
2023-02-08
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K pbsv_8k.htm   iXBRL 8-K 30818
2 AMENDED AND RESTATED pbsv_ex31.htm EX-3.1 86302
  Complete submission text file 0001654954-23-001509.txt   253541

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pbsv-20230208.xsd EX-101.SCH 5720
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbsv-20230208_lab.xml EX-101.LAB 13115
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pbsv-20230208_cal.xml EX-101.CAL 898
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbsv-20230208_pre.xml EX-101.PRE 8222
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbsv-20230208_def.xml EX-101.DEF 2099
9 EXTRACTED XBRL INSTANCE DOCUMENT pbsv_8k_htm.xml XML 3247
Mailing Address INDUSTRIAL ZONE STREET 1 LOT 14 DORADO PR 00646
Business Address INDUSTRIAL ZONE STREET 1 LOT 14 DORADO PR 00646 787-278-2709
Pharma-Bio Serv, Inc. (Filer) CIK: 0001304161 (see all company filings)

IRS No.: 200653570 | Fiscal Year End: 1031
Type: 8-K | Act: 34 | File No.: 000-50956 | Film No.: 23601579
SIC: 8742 Services-Management Consulting Services